HE4 antigen-autoantibody complexes complement CA125 for detecting early stage ovarian cancer

BACKGROUND: Early detection of ovarian cancer could significantly improve patient outcomes. CA125 is elevated in sera from approximately 60% of patients with early stage I-II disease. Sensitivity might be improved by combining CA125 with other biomarkers. Among potential biomarkers, antigen-autoanti...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Cancer
Auteurs principaux: Yang, Wei-Lei, Lu, Zhen, Guo, Jing, Fellman, Bryan M., Ning, Jing, Lu, Karen H., Menon, Usha, Kobayashi, Makoto, Hanash, Samir, Celestino, Joseph, Skates, Steven J., Bast, Robert C.
Format: Artigo
Langue:Inglês
Publié: 2019
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6992519/
https://ncbi.nlm.nih.gov/pubmed/31714597
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.32582
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires